NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy – GlobeNewswire

NextCure and Avere Therapeutics Announce combination to Advance Once-Weekly Oral IL-23 Therapy  GlobeNewswire

Source: news.google.com

Leave a Comment

Your email address will not be published. Required fields are marked *